###begin article-title 0
###xml 25 30 <span type="species:ncbi:10090">Mouse</span>
An Antibiotic-Responsive Mouse Model of Fulminant Ulcerative Colitis
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 377 382 <span type="species:ncbi:10090">mouse</span>
###xml 429 434 <span type="species:ncbi:9606">human</span>
###xml 697 702 <span type="species:ncbi:9606">human</span>
###xml 703 711 <span type="species:ncbi:9606">patients</span>
The constellation of human inflammatory bowel disease (IBD) includes ulcerative colitis and Crohn's disease, which both display a wide spectrum in the severity of pathology. One theory is that multiple genetic hits to the host immune system may contribute to the susceptibility and severity of IBD. However, experimental proof of this concept is still lacking. Several genetic mouse models that each recapitulate some aspects of human IBD have utilized a single gene defect to induce colitis. However, none have produced pathology clearly distinguishable as either ulcerative colitis or Crohn's disease, in part because none of them reproduce the most severe forms of disease that are observed in human patients. This lack of severe IBD models has posed a challenge for research into pathogenic mechanisms and development of new treatments. We hypothesized that multiple genetic hits to the regulatory machinery that normally inhibits immune activation in the intestine would generate more severe, reproducible pathology that would mimic either ulcerative colitis or Crohn's disease.
###end p 2
###begin title 3
Methods and Findings
###end title 3
###begin p 4
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 181 186 <span type="species:ncbi:9606">human</span>
###xml 312 316 <span type="species:ncbi:10090">mice</span>
We generated a novel mouse line (dnKO) that possessed defects in both TGFbetaRII and IL-10R2 signaling. These mice rapidly and reproducibly developed a disease resembling fulminant human ulcerative colitis that was quite distinct from the much longer and more variable course of pathology observed previously in mice possessing only single defects. Pathogenesis was driven by uncontrolled production of proinflammatory cytokines resulting in large part from T cell activation. The disease process could be significantly ameliorated by administration of antibodies against IFNgamma and TNFalpha and was completely inhibited by a combination of broad-spectrum antibiotics.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
###xml 486 491 <span type="species:ncbi:9606">human</span>
###xml 623 631 <span type="species:ncbi:9606">patients</span>
Here, we develop to our knowledge the first mouse model of fulminant ulcerative colitis by combining multiple genetic hits in immune regulation and demonstrate that the resulting disease is sensitive to both anticytokine therapy and broad-spectrum antibiotics. These findings indicated the IL-10 and TGFbeta pathways synergize to inhibit microbially induced production of proinflammatory cytokines, including IFNgamma and TNFalpha, which are known to play a role in the pathogenesis of human ulcerative colitis. Our findings also provide evidence that broad-spectrum antibiotics may have an application in the treatment of patients with ulcerative colitis. This model system will be useful in the future to explore the microbial factors that induce immune activation and characterize how these interactions produce disease.
###end p 6
###begin p 7
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
Paul Allen and colleagues describe the development of a mouse model of fulminant ulcerative colitis with multiple genetic hits in immune regulation which can be moderated by anti-cytokine therapy and broad-spectrum antibiotics.
###end p 7
###begin title 8
Editors' Summary
###end title 8
###begin title 9
Background.
###end title 9
###begin p 10
###xml 194 200 <span type="species:ncbi:9606">people</span>
###xml 1055 1061 <span type="species:ncbi:9606">people</span>
###xml 1068 1074 <span type="species:ncbi:9606">people</span>
Inflammatory bowel disease (IBD), a group of disorders characterized by inflammation (swelling) of the digestive tract (the tube that runs from the mouth to the anus), affects about 1.4 million people in the US. There are two main types of IBD. In Crohn's disease, which can affect any area of the digestive tract but most commonly involves the lower part of the small intestine (small bowel), all the layers of the intestine become inflamed. In ulcerative colitis, which primarily affects the colon (large bowel) and the rectum (the part of the bowel closest to the anus), only the lining of the bowel becomes inflamed, the cells in this lining die, and sores or ulcers form. Both types of IBD most commonly develop between the ages of 15 and 35 years, often run in families, and carry an increased risk of cancer. Symptoms-usually diarrhea and abdominal cramps-can be mild or severe and the disorder can develop slowly or suddenly. There is no medical cure for IBD, but drugs that modulate the immune system (for example, corticosteroids) can help some people. Some people benefit from treatment with drugs that specifically inhibit "proinflammatory cytokines," proteins made by the immune system that stimulate inflammation (for example, TNFalpha and INFgamma). When medical therapy fails, surgery to remove the affected part of the bowel may be necessary.
###end p 10
###begin title 11
Why Was This Study Done?
###end title 11
###begin p 12
###xml 42 48 <span type="species:ncbi:9606">people</span>
###xml 278 283 <span type="species:ncbi:9606">human</span>
###xml 615 619 <span type="species:ncbi:10090">mice</span>
###xml 839 844 <span type="species:ncbi:10090">mouse</span>
###xml 951 956 <span type="species:ncbi:9606">human</span>
Exactly what causes IBD is not clear, but people with IBD seem to have an overactive immune system. The immune system normally protects the body from harmful substances but in IBD it mistakenly recognizes the food substances and "good" bacteria that are normally present in the human gut as foreign and hence reacts against them. As a result, immune system cells accumulate in the lining of the bowel and cause inflammation. Several different pathways usually prevent inappropriate immune activation, so could IBD be caused by alterations in one or several of these immune regulatory pathways? In previous studies, mice with a defect in just one pathway have developed mild intestinal abnormalities but not the problems seen in the most severe forms of IBD. In this study, therefore, the researchers have generated and characterized a new mouse line with defects in two immune regulatory pathways to see whether this might be a better animal model of human IBD.
###end p 12
###begin title 13
What Did the Researchers Do and Find?
###end title 13
###begin p 14
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 615 619 <span type="species:ncbi:10090">Mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
###xml 725 731 <span type="species:ncbi:9606">people</span>
###xml 931 935 <span type="species:ncbi:10090">mice</span>
###xml 1069 1073 <span type="species:ncbi:10090">mice</span>
###xml 1226 1230 <span type="species:ncbi:10090">mice</span>
To make their new mouse line, the researchers mated mice that had a defective TGFbeta signaling pathway in their T lymphocytes with mice that had a defective IL-10 signaling pathway. Both these pathways are anti-inflammatory, and mice with defects in either pathway develop mild and variable inflammation of the colon (colitis) by age 3-4 months. By contrast, the doubly defective mice (dnKO mice) failed to thrive, lost weight, and died by 4-6 weeks of age. The colons of 4- to 5-week old dnKO mice were inflamed and ulcerated (some changes were visible in 3-week-old mice) and contained many immune system cells. Mice with a single defective signaling pathway had no gut abnormalities at this age. The dnKO mice, just like people with IBD, had higher than normal blood levels of IFNgamma, TNFalpha, and other proinflammatory cytokines; these raised levels were the result of abnormal lymphocyte activation. Treatment of the dnKO mice with a combination of agents that neutralize IFNgamma and TNFalpha (anti-cytokine therapy) greatly reduced the colitis seen in these mice; neutralization of IFNgamma alone had some beneficial effects, but neutralization of TNFalpha alone had no effect. Finally, early treatment of the dnKO mice with broad-spectrum antibiotics completely inhibited colitis.
###end p 14
###begin title 15
What Do These Findings Mean?
###end title 15
###begin p 16
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 386 391 <span type="species:ncbi:10090">mouse</span>
###xml 819 825 <span type="species:ncbi:9606">people</span>
These findings suggest that dnKO mice are a good model for fulminant (severe and rapidly progressing) ulcerative colitis and support the idea that IBD involves multiple genetic defects in immune regulation. They also indicate that the IL-10 and the TGFbeta signaling pathways normally cooperate to inhibit the inappropriate immune responses to intestinal bacteria seen in IBD. This new mouse model should help researchers unravel what goes wrong in IBD and should also help them develop new treatments for ulcerative colitis. More immediately, these findings suggest that combined anti-cytokine therapy may be a better treatment for ulcerative colitis than single therapy. In addition, they suggest that clinical studies should be started to test whether broad-spectrum antibiotics can ameliorate ulcerative colitis in people.
###end p 16
###begin title 17
Additional Information.
###end title 17
###begin p 18
Please access these Web sites via the online version of this summary at .
###end p 18
###begin p 19
The Medline Plus Encyclopedia has pages on  and on  (in English and Spanish)
###end p 19
###begin p 20
Information is available from the UK National Health Service Direct Health Encyclopedia about  and
###end p 20
###begin p 21
The US National Institute of Diabetes and Digestive and Kidney Diseases provides information on  and
###end p 21
###begin p 22
###xml 28 36 <span type="species:ncbi:9606">patients</span>
Information and support for patients with inflammatory bowel disease and their caregivers is provided by the  and by the
###end p 22
###begin title 23
Introduction
###end title 23
###begin p 24
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b001">1</xref>
###xml 658 659 658 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b002">2</xref>
Inflammatory bowel disease (IBD) is an idiopathic disease of the intestinal tract with the hallmark features of mucosal inflammation and loss of barrier function. Although the exact mechanisms for IBD induction and progression are not completely understood, unchecked immune responses to enteric bacteria are critical for pathogenesis (reviewed in [1]). The clinical presentation of IBD occurs over a wide spectrum from chronic indolent to acute fulminant disease. A recent hypothesis is that susceptibility to disease, including the variation in presentation, may be a result of alterations of multiple pathways that control intestinal mucosal homeostasis [2].
###end p 24
###begin p 25
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b001">1</xref>
###xml 280 281 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b002">2</xref>
###xml 370 371 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b003">3</xref>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b006">6</xref>
###xml 622 623 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b003">3</xref>
###xml 624 625 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b005">5</xref>
###xml 626 627 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b007">7</xref>
###xml 628 629 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b009">9</xref>
###xml 23 29 <span type="species:ncbi:10090">murine</span>
###xml 436 441 <span type="species:ncbi:9606">human</span>
At least ten different murine models of IBD involving single gene manipulations have been developed and demonstrate the role for proper development/maintenance of specific subsets of T cells and control of inflammatory cytokine production in regulation of disease (reviewed in [1,2]), as well as revealing a crucial role for enteric bacteria in inducing disease (e.g., [3-6]). While a variety of existing models recapitulate aspects of human IBD, many are limited by variable penetrance, delayed development of characteristic disease pathology, and, in some cases, induction of nonspecific severe multiorgan autoimmunity [3-5,7-9]. Additionally, none of these models consistently and predictably mimics the most severe and acute presentation of either ulcerative colitis or Crohn's disease. This animal-to-animal variability in disease penetrance and severity poses a significant challenge for efforts to experimentally manipulate the course of disease in these models.
###end p 25
###begin p 26
###xml 387 390 387 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b010">10</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b011">11</xref>
###xml 763 765 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b012">12</xref>
###xml 766 768 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b016">16</xref>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 553 558 <span type="species:ncbi:10090">mouse</span>
###xml 570 575 <span type="species:ncbi:9606">human</span>
Because the current number of known genetic manipulations that can produce a partial IBD phenotype is at least ten, and the minimum number of multiple genetic hits is two, the resulting number of possible two-hit combinations is 45. We chose to utilize a model involving the loss of the IL-10 signaling pathway because uncharacterized loci that increased the severity of colitis in IL-10-/- mice have been defined using a genetic approach [10,11]. These findings support the hypothesis that alterations of multiple loci can exacerbate pathology both in mouse models and human IBD. Because both IL-10 and TGFbeta signaling pathways have been demonstrated to be anti-inflammatory, in part through control of proinflammatory cytokines such as IFNgamma and TNFalpha [12-16], we hypothesized that genetic ablation of these two pathways would synergize to elicit more acute pathology than loss of either pathway alone.
###end p 26
###begin title 27
Materials and Methods
###end title 27
###begin title 28
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 28
###begin p 29
###xml 111 112 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b008">8</xref>
###xml 144 147 141 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 167 168 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b009">9</xref>
###xml 606 609 603 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 679 682 676 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1033 1036 1015 1018 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1093 1096 1072 1075 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1182 1185 1158 1161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1203 1206 1179 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1268 1271 1244 1247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1295 1298 1268 1271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1341 1344 1311 1314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
###xml 732 736 <span type="species:ncbi:10090">mice</span>
###xml 846 850 <span type="species:ncbi:10090">Mice</span>
###xml 1016 1020 <span type="species:ncbi:10090">mice</span>
###xml 1064 1069 <span type="species:ncbi:10090">mouse</span>
###xml 1118 1122 <span type="species:ncbi:10090">mice</span>
###xml 1186 1190 <span type="species:ncbi:10090">mice</span>
###xml 1207 1211 <span type="species:ncbi:10090">mice</span>
###xml 1365 1369 <span type="species:ncbi:10090">mice</span>
All female or male C57BL/6 (WT) (The Jackson Laboratory), dominant negative TGFbetaRII mice (supplied by RAF) [8], and CRF2-4-deficient (IL-10R2-/-) mice (Genentech) [9] were on the C57BL/6 background. Importantly, all mice used in these experiments were bred and housed in a specific pathogen-free barrier facility at Washington University. Animal protocols were reviewed and approved by the Washington University animal studies committee. Animals were used between 3-6 wk of age for this study, with the exception of long-term measurements that were taken out to approximately 3-3.5 mo of age. The CRF2-4-/- mice lack the IL-10R2 receptor protein and are referred to as IL-10R2-/- in this report. The dominant negative TGFbetaRII mice (referred to as dnTGFbetaRII), express a dominant negative TGFbetaRII solely in the CD4 and CD8 compartment. Mice that were unresponsive to IL-10R2 signaling in all compartments and TGFbeta signaling specifically in the T cell compartment were generated by breeding dnTGFbetaRII mice with IL-10R2-/- to yield a novel strain of mouse, dnTGFbetaRII x IL-10R2-/-, referred to as dnKO mice. The breeding scheme involved mating dnTGFbetaRII x IL-10R2+/- mice with IL-10R2-/- mice to generate four genotypes of littermates: dnKO, IL-10R2-/-, dnTGFbetaRII x IL-10R2+/- (referred to as dnTGFbetaRII), and IL-10R2+/- (referred to as WT) mice.
###end p 29
###begin title 30
Weight Loss Measurements
###end title 30
###begin p 31
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were weighed every day or every other day using a portable electronic Ohaus scale (VWR International). Weights were recorded to a tenth of a gram.
###end p 31
###begin title 32
Harvesting and Preparation of Intestines for Hematoxlyin and Eosin Staining
###end title 32
###begin p 33
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were humanely killed and large intestines were harvested, flushed with PBS, and fixed with Bouin's fixative (70% picric acid/25% formaldehyde [37%]/5% glacial acetic acid). Intestines were cut from cecum to rectum, splayed out, and pinned with insect pins (Carolina Biological) onto a square Petri dish filled with wax (Carolina Biological). Intestines were incubated in Bouin's fix for 4-8 h and then placed in 70% ethanol overnight. Pictures of the whole view or whole mounts of the intestines were taken using either a digital camera or an Olympus 52 x 12 whole mount camera (Diagnostic Instruments), respectively. Intestines were paraffin embedded, cut in 5-mum sections, and stained with hematoxylin and eosin (HE) at the histology core (Washington University, St. Louis, Missouri, United States).
###end p 33
###begin title 34
Gross Morphologic and Microscopic Parameters for Scoring the Severity of Mucosal Damage
###end title 34
###begin p 35
Images of the rectal mucosal surface were obtained using a dissecting stereoscope and were scored in a blinded fashion by an anatomic pathologist (TSS) using the following scoring system: 0, normal; 1, focal ulcers present; 2, ulcers and diffuse, mild mucosal thickening; and 3, ulcers and diffuse, severe mucosal thickening. Blinded microscopic analysis of histologic HE-stained sections was performed using an Olympus Bx51 microscope at 200x magnification to determine rectal crypt heights, crypt widths, and goblet cell number and 400x to determine surface epithelial heights and the number of mitotic and apoptotic bodies. Only crypt-surface units that were well oriented (i.e., the entire length of the crypt could be discerned) were evaluated.
###end p 35
###begin title 36
Isolation of Cells from the Lamina Propria/Mucosally Associated Lymphoid Tissue
###end title 36
###begin p 37
###xml 177 179 177 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 186 188 186 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 305 307 305 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 314 316 314 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 259 265 <span type="species:ncbi:9913">bovine</span>
Intestines were harvested and flushed with PBS. The cecum, descending colon, and rectum were cut into small pieces and washed six times with CMF-HEPES solution (0.015 M HEPES/Ca2+ and Mg2+ free HBSS [pH 7.2]). Intestines were incubated with CMF/BGS/EDTA (10% bovine growth serum/0.015 M HEPES/5 mM EDTA/Ca2+ and Mg2+ free HBSS [pH 7.2]) solution at 37 degreesC for 15 min, shaking at approximately275 rpm. After removing the supernatants, the process was repeated three more times with CMF/BGS/EDTA. The remaining intestinal tissue pieces were shaken for 5 min at 37 degreesC in RPMI/10% BGS. After removal of the media, the tissue was incubated with RPMI/10% BGS containing 1 mg/ml collagenase type IV (Sigma) for 1 h at 37 degreesC, shaking at approximately275 rpm. This process was repeated two more times and supernatants containing the lamina propria/mucosally associated lymphoid tissue (MALT) cells were collected, centrifuged, and resuspended in CMF-HEPES at each step. For cytokine analysis, a 40%-100% Percoll gradient was also run to remove any dead cells or debris.
###end p 37
###begin title 38
Flow Cytometric Analysis
###end title 38
###begin p 39
Cells were surface stained at 4 degreesC for 10-15 min with antibodies against CD4 FITC/PE or /PE-Cy5, CD8 FITC/PE or /PECy5, Gr1 FITC, CD25PE, CD45.2 FITC or PE, CD62L PE, B220 FITC, and DX5 biotin-conjugated antibodies (BD Pharmingen or Biolegend). For biotinylated antibodies, streptavidin PE or streptavidin APC conjugated secondaries (Caltag) were added to the cells in a second incubation step. Cells were analyzed by flow cytometry on a FACScan or a FACsCaliber (BD Biosciences) using CellQuest analysis software. For studies of live cells, 7AAD (Sigma) was added prior to analysis.
###end p 39
###begin title 40
Intracellular Cytokine Staining
###end title 40
###begin p 41
Cells were harvested, centrifuged, and then resuspended in RPMI 1640 supplemented with 10% FCS (HyClone), 2 mM Glutamax (Life Technologies), 0.5 muM 2-ME (Sigma), and 50 mug/ml gentamicin (Invitrogen Life Technologies) containing 50 ng/ml PMA and 500 ng/ml ionomycin (Sigma) and incubated for 4 h at 37 degreesC. Brefeldin A (Sigma) was added during the last 2 h of culture at 10 mug/ml. Cells were surface stained for CD4 or CD8 for 15 min at 4 degreesC (BD Pharmingen). Stained cells were fixed in 2%-4% paraformaldehyde for 20 min at RT prior to permeabilization with 0.5% saponin/1% BSA/PBS. Intracellular staining for the cells was conducted at RT for 30 min using anti-IL-17 PE (4 mug/ml) (Biolegend), anti-IFNgamma FITC (2.5 mug/ml), and anti-TNFalpha PE (4 mug/ml), conjugated antibodies.
###end p 41
###begin title 42
Serum Cytokine Concentrations
###end title 42
###begin p 43
###xml 11 15 <span type="species:ncbi:10090">mice</span>
Blood from mice was clotted on ice for 1 h. The samples were then centrifuged at 10,000 rpm for 5 min, and the serum was removed. All serum samples were stored at 20 degreesC prior to analysis. The concentrations of IFNgamma, TNFalpha, and IL-6 was determined using an inflammatory cytokine cytometric bead analysis (CBA) kit (BD Pharmingen) and analyzed on a FACScan (BD biosciences) using CBA analysis software. The lower limit of detection for all cytokines was set to 20 pg/ml, the minimum quantifiable value, as described in the kit manual.
###end p 43
###begin title 44
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
CD4+ T Cell Transfer
###end title 44
###begin p 45
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 202 203 199 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 216 217 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 255 258 252 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
CD4+ T cells were purified from the lymph nodes of 3-wk-old WT B6, IL-10R2-/-, dnTGFbetaRII, and dnKO mice by positive selection using Miltenyi CD4 beads according to the manufacturer's protocol. 2 x 106 purified CD4+ T cells were transferred into B6.RAG1-/- mice by IP injection, and the weights of the mice were determined every other day. Five weeks post-T cell transfer, mice were humanely killed and the intestines were harvested, flushed with PBS, fixed with Bouin's fixative, and prepared according to the methods discussed above.
###end p 45
###begin title 46
Cytokine Neutralization
###end title 46
###begin p 47
###xml 112 114 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b017">17</xref>
###xml 152 154 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b018">18</xref>
###xml 5 9 <span type="species:ncbi:10090">mice</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
dnKO mice were injected IP with either 1 mg of a hamster anti-PIP isotype control, hamster anti-IFNgamma (H22) [17], hamster anti-TNFalpha (TN3-19.12) [18], or a combination of anti-IFNgamma and anti-TNFalpha at 2 wk and 3 wk of age. All neutralizing antibodies were a generous gift from Robert Schreiber. Intestines were harvested from mice at 4 wk of age, fixed in Bouin's solution, paraffin embedded, and HE stained.
###end p 47
###begin title 48
Antibiotic Experiments
###end title 48
###begin p 49
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b019">19</xref>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b020">20</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b021">21</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
Mice received drinking water containing 0.66 mg/ml ciprofloxacin [19] and 2.5 mg/ml metronidazole (Sigma) [20] beginning at 24 d of age. Previous reports (e.g., [21]) have suggested occasional refusal of mice to drink water that contains antibiotics, so we included 20 mg/ml sugar-sweetened grape Kool-Aid Mix (Kraft Foods) in the water to encourage consumption. The antibiotic solution was passed through a sterilizing, 0.22-mum, nonpyrogenic cellulose acetate filter (Corning) before delivery to mice and was replaced with freshly prepared solution two to three times per week. For analysis of weight gain on antibiotics, mice were tracked over a 3-wk treatment period from 24 to 45 d of age.
###end p 49
###begin title 50
Statistical Analysis
###end title 50
###begin p 51
###xml 178 181 175 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 230 231 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 357 358 354 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 433 434 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 467 468 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 594 595 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 839 843 <span type="species:ncbi:10090">mice</span>
Statistical analysis was performed using Prism v4.03 (GraphPad Software) and Stata10 (StataCorp) software. To compare data obtained from the analysis of WT, dnTGFbetaRII, IL-10R2-/-, and dnKO mice, a one-way analysis of variance (F test) was used to determine if statistically significant differences existed between groups; the degrees of freedom for each F test were indicated in brackets (treatment, residual). In cases where the F test revealed such differences (p < 0.05), a Bonferroni's multiple comparison post-test was used to determine statistical significance between any two groups (p < 0.05 was considered statically significant). Similar analysis was employed for T cell transfer experiments and anticytokine treatments. The Kaplan-Meier method was used to analyze survival of T cell transfer recipient and antibiotic-treated mice. Statistical significance of survival differences between groups was calculated in GraphPad Prism using the log-rank test. To analyze and compare growth data, generalized estimating equations were generated using Stata10 software.
###end p 51
###begin title 52
Results
###end title 52
###begin title 53
###xml 76 80 <span type="species:ncbi:10090">Mice</span>
Failure to Thrive Followed by Rapid Weight Loss and Early Mortality in dnKO Mice
###end title 53
###begin p 54
###xml 476 477 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b008">8</xref>
###xml 478 479 475 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b009">9</xref>
###xml 482 487 <span type="species:ncbi:9606">Human</span>
###xml 559 567 <span type="species:ncbi:9606">patients</span>
Intestinal homeostasis is partially maintained through the actions of inhibitory cytokines that regulate mucosal inflammation. A single defect in either T cell TGFbetaRII or global IL-10R2 signaling results in spontaneous colitis induction. However, the ability to further study pathogenesis and treatments for IBD in these systems is limited because of the variability in penetrance of pathology and delayed onset of disease (typically up to 3-4 mo) observed in both models [8,9]. Human IBD shows a spectrum of disease severity that includes a population of patients who present with acute, fulminant, and life-threatening disease. The basis for this more severe form of disease is unclear, and we hypothesized that it may reflect a culmination of impairments to multiple genes. Therefore, we wanted to establish whether combining multiple genetic defects in immune regulation would be sufficient to significantly exacerbate colitis.
###end p 54
###begin p 55
###xml 38 41 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 107 110 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 343 346 331 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 497 505 485 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g001">Figure 1</xref>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 551 555 <span type="species:ncbi:10090">mice</span>
We bred dnTGFbetaRII mice with IL-10R2-/- mice to generate a novel mouse strain, the dnTGFbetaRII x IL-10R2-/- (dnKO), which has impaired TGFbetaRII and IL-10R2 signaling in the T cell compartment and deficiencies in IL-10R2 dependent signaling in all cells. Total body weights of dnKO and controls (consisting of WT, dnTGFbetaRII, and IL-10R2-/- mice) showed that dnKO mice failed to thrive by 3-4 wk and demonstrated rapid weight loss culminating in death as compared to all controls by 4-6 wk (Figure 1A). This phenotype was 100% penetrant in dnKO mice, and no apparent gender difference in weight loss was observed (unpublished data). These data indicate that the kinetics of disease induction was significantly accelerated through the combination of two separate genetic deficiencies.
###end p 55
###begin title 56
###xml 5 9 <span type="species:ncbi:10090">Mice</span>
dnKO Mice Fail to Thrive and Waste Rapidly Because of a Fatal, 100% Penetrant Disease Process Localized to the Cecum and Colon
###end title 56
###begin p 57
###xml 57 58 57 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 79 80 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 94 97 91 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 99 100 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 117 118 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
###xml 510 515 <span type="species:ncbi:10090">mouse</span>
(A) Plot of the average weight/group versus time for WT (n = 4), dnTGFbetaRII (n = 4), IL-10R2-/- (n = 5), and dnKO (n = 11) mice. All mice were weighed two or three times per week from 3 to 18 wk of age. Error bars were omitted for the sake of clarity. In all cases the experimental error was </= 8% of the mean value. Individual mice died or were humanely killed when their weight reached </= 70% of their maximal weight. The line representing dnKO average weight terminates with the death of the final dnKO mouse.
###end p 57
###begin p 58
###xml 115 118 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
(B) Whole-mount images of the mucosal surface of the descending colon from 4- to 5-wk-old WT, dnTGFbetaRII, IL-10R2-/-, and dnKO mice. The cecum and entire colons were harvested, dissected, opened, pinned in Bouin's fixative, and examined for gross morphology. The dnKO mice all contained major pathologic alterations including severe ulceration (e.g., red arrow) and mucosal thickening in the cecum, descending colon, and rectum (**), as well as minor alterations (*) in the ascending colon.
###end p 58
###begin title 59
Development of Spontaneous Fulminant Ulcerative Colitis upon Loss of TGFbetaRII and IL-10R2 Signaling
###end title 59
###begin p 60
###xml 50 53 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 251 255 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
Because individually both dnTGFbetaRII and IL-10R2-/- mice spontaneously develop colitis, we wanted to establish whether the colon was the primary target and cause of the wasting phenotype detected in dnKO mice. Gross and histological surveys of dnKO mice >/=4 wk of age revealed only small, occasional clusters of lymphocytes located in the portal triads of the liver and around bronchi of the lungs, without any tissue destruction (unpublished data). No abnormalities were observed in the heart, kidney, stomach, and small intestine of dnKO mice.
###end p 60
###begin p 61
###xml 288 296 288 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g001">Figure 1</xref>
###xml 407 415 407 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g001">Figure 1</xref>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
However, at this time, striking disruptions in the gross morphology of the entire cecum, descending colon, and rectum in dnKO mice were observed, with the overall architecture of the ascending colon being relatively spared. The cecum (unpublished data) and descending colon/rectum areas (Figure 1B) of dnKO mice showed a diffuse and marked thickening of the mucosa accompanied by areas of focal ulceration (Figure 1B). This phenotype was severe, confluent, regionally consistent, and 100% penetrant in all dnKO mice.
###end p 61
###begin p 62
###xml 41 44 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 199 202 193 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 352 355 343 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 583 592 574 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050041-sg001">Figure S1</xref>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
Analysis of WT, dnTGFbetaRII, and IL-10R2-/- control mice at 4-5 wk of age revealed that the cecum and colons were generally unaffected. We detected colonic pathology in only dnTGFbetaRII and IL-10R2-/- mice that were considerably older (3-4 mo). In contrast to the diffuse mucosal thickening that is the hallmark of dnKO mice, dnTGFbetaRII and IL-10R2-/- mice colons contained a focal and variable disease process that typically resulted in ulcerations found near junctions, including the ileal-cecal junction, ascending-to-descending colon transition and the anal-rectal junction (Figure S1).
###end p 62
###begin p 63
###xml 57 60 54 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 137 145 134 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g002">Figure 2</xref>
###xml 147 148 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g002">2</xref>
###xml 565 573 562 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g002">Figure 2</xref>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
Histological examination of WT, dnTGFbetaRII, and IL-10R2-/- colons revealed relatively normal intestinal architecture at 4-5 wk of age (Figure 2A-2C). In contrast, dnKO mice had severe and diffuse alterations in mucosal structure that correlated with the gross findings described above and included marked extensive epithelial hyperplasia, diminished goblet cell and crypt number, erosion of surface epithelial cells, numerous crypt abscesses, and mixed leukocytic infiltrates localized in both the mucosa and submucosa of the cecum, descending colon, and rectum (Figure 2D and unpublished data). Although leukocytic infiltrates were detected in the ascending colon, the epithelium and goblets cells in this region were relatively spared (unpublished data).
###end p 63
###begin title 64
###xml 5 9 <span type="species:ncbi:10090">Mice</span>
dnKO Mice Develop Diffuse Fulminant Ulcerative Colitis That Is Not Detected in Age-matched Controls
###end title 64
###begin p 65
###xml 37 40 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 93 101 90 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g001">Figure 1</xref>
###xml 188 191 182 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
Colons from WT, dnTGFbetaRII, IL-10R2-/-, and dnKO mice were isolated at 4-5 wk of age as in Figure 1. Images from HE stained sections of rectums from (A) WT, (B) dnTGFbetaRII, (C) IL-10R2-/-, and (D) dnKO mice are shown at low power (100x). One higher power image (400x) is shown for (A-C, right images) and four higher-power images (I-IV) for (D). The boxed region on the lower power image indicates the location of the higher magnification(s). The four highlighted regions in the dnKO image (D) reflect (I) epithelial hyperplasia, presence of increased M-phase cells, and goblet cell loss in crypts; (II) eroded surface epithelium; (III) mucosal and submucosal leukocytic inflammation; and (IV) the presence of a crypt abscess. Bars, 200 mum for 100x images and 30 mum for 400x images.
###end p 65
###begin p 66
###xml 513 521 512 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g003">Figure 3</xref>
###xml 527 528 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g003">3</xref>
###xml 635 643 634 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g003">Figure 3</xref>
###xml 692 700 691 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g003">Figure 3</xref>
###xml 756 758 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b022">22</xref>
###xml 826 834 825 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g003">Figure 3</xref>
###xml 884 892 883 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g003">Figure 3</xref>
###xml 1003 1005 1002 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b022">22</xref>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 551 555 <span type="species:ncbi:10090">mice</span>
###xml 903 907 <span type="species:ncbi:10090">mice</span>
Because the pathology of dnKO mice was diffuse and consistent, we were able to objectively quantify specific features of the histopathology that reflect disease severity instead of utilizing histology scores that are generally more effective for focal and variable disease processes. For example, in the rectums of dnKO mice, we found a statistically significant loss of crypts, as demonstrated by decreased numbers of crypts per field (each field, 870 mum) and increased crypt width as compared to all controls (Figure 3A and 3B). Additionally, dnKO mice showed significant epithelial hyperplasia indicated by increased crypt height (Figure 3C) and elevated M-phase bodies per crypt ratios (Figure 3D), a response that is typical of injury in this organ [22]. We also noted an increased number of apoptotic bodies per crypt (Figure 3E) and decreased surface epithelial cell heights (Figure 3F) in dnKO mice. All of these parameters are indicative of a mucosal response to inflammatory stimulus (e.g., [22]).
###end p 66
###begin title 67
###xml 64 69 <span type="species:ncbi:9606">Human</span>
dnKO Histopathology Shares Features of Inflammation Detected in Human Ulcerative Colitis
###end title 67
###begin p 68
###xml 128 131 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
Objective, quantitative morphometric analysis of the rectal histopathology was conducted on 4-5-wk-old WT, dnTGFbetaRII, IL-10R2-/-, and dnKO mice.
###end p 68
###begin p 69
(A-D) Using well-oriented sections, we measured crypt loss/drop out by examining (A) the number of crypts per field (a field, 870 mum) and (B) crypt width. Epithelial hyperplasia was assayed by measuring (C) crypt height (from the base of the crypt to the basal side of the surface epithelial cells) and (D) the ratio of M-phase cells/crypt.
###end p 69
###begin p 70
###xml 205 206 203 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 233 234 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 256 257 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 273 274 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 289 290 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 306 307 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 322 323 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 339 340 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 355 356 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 372 373 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 388 389 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 405 406 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 420 421 418 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 437 438 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 455 456 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 527 528 525 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 654 655 652 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 728 729 726 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 753 754 751 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
(E) The ratio of apoptotic bodies/crypt and (F) surface epithelial heights were quantified to determine effects on cell death and barrier epithelial changes. All measurements are the averages +/- SEM from n = 5-8 mice per group. The F test results are (A) F(3,23) = 26.74, p < 0.0001; (B) F(3,23) = 21.17, p < 0.0001; (C) F(3,23) = 53.53, p < 0.0001; (D) F(3,25) = 89.47, p < 0.0001; (E) F(3,24) = 7.574, p = 0.001; (F) F(3,23) = 41.35, p < 0.0001. Where F testing revealed statistically significant differences within groups (p < 0.05), individual means were compared by Bonferroni's multiple comparison test. All statistically significant comparisons (p < 0.05) between any two groups were indicated with a bracket. The exact p-value is listed unless p < 0.001 (indicated by ***).
###end p 70
###begin p 71
###xml 268 276 268 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g004">Figure 4</xref>
###xml 366 367 366 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 370 372 370 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 393 394 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 397 399 397 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 413 414 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 434 435 434 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 438 446 438 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g004">Figure 4</xref>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
In accordance with the histological data reflecting intestinal inflammation, isolation of lamina propria and MALT infiltrates in the cecum, descending colon, and rectal regions of dnKO and control mice demonstrated a 10-fold increase in cell numbers in the dnKO mice (Figure 4). The cellular composition consisted mainly of T cells, immature myeloid/monocytes (CD11b+Gr1lo), neutrophils (CD11b+Gr1hi), NK/NKT (DX5+), and B cells (B220+) (Figure 4). The increase in the cell number by this method correlates with that seen in tissue sections from control and dnKO mice stained with antibodies for markers of each immune cell type (unpublished data).
###end p 71
###begin title 72
###xml 14 18 <span type="species:ncbi:10090">Mice</span>
Diseased dnKO Mice Have Diverse Leukocytic Infiltrates Located in the Cecum and Colon
###end title 72
###begin p 73
###xml 133 136 130 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 213 214 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 299 300 294 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 331 332 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 339 340 334 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 376 377 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 380 382 375 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 403 404 398 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 407 409 402 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 423 424 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 444 445 439 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 484 485 479 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 604 605 599 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 644 645 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 661 662 656 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 676 677 671 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 687 688 682 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 704 705 699 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 719 720 714 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 730 731 725 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 747 748 742 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 793 794 788 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 810 811 805 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 835 836 830 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 852 853 847 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 878 879 873 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 895 896 890 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 916 917 911 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 933 934 928 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 988 989 983 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1061 1062 1056 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1086 1087 1081 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 493 497 <span type="species:ncbi:10090">mice</span>
Lamina propria/MALT cells from the pooled cecum, descending colon, and rectum were isolated from 4-5-wk-old WT, dnTGFbetaRII, IL-10R2-/-, and dnKO mice. Shown are the averages +/-SEM for the total number of CD45.2+ (hematopoietic) cells located within the tissue as well as for each subset of CD45.2+ cells stained for T cells (CD4+ or CD8+), immature myeloid/monocytes (CD11b+Gr1lo), neutrophils (CD11b+Gr1hi), NK/NKT (DX5+), and B cells (B220+) from seven separate experiments with n = 6-15 mice per group. Results were consistent with observations using immunofluorescence microscopy (not shown). The F test results are: total immune cells, F(3,32) = 69.76, p < 0.0001; CD4+ T cells, F(3,32) = 23.16, p < 0.0001; CD8+ T cells, F(3,32) = 9.779, p < 0.0001; monocytes/immature myeloid cells, F(3,16) = 11.57, p = 0.0003; neutrophils, F(3,16) = 16.59, p < 0.0001; NK/NKT cells, F(3,16) = 10.93, p = 0.0005; B cells, F(3,27) = 27.47, p < 0.0001. All statistically significant comparisons (p < 0.05) between any two groups are indicated with a bracket. The exact p-value is listed unless p < 0.001 (indicated by ***).
###end p 73
###begin p 74
###xml 183 192 183 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g001">Figures 1</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050041-sg001">S1</xref>
###xml 290 298 290 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g002">Figure 2</xref>
###xml 345 354 345 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g001">Figures 1</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050041-sg001">S1</xref>
###xml 397 405 397 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g002">Figure 2</xref>
###xml 451 460 451 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g002">Figures 2</xref>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g003">3</xref>
###xml 503 511 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g002">Figure 2</xref>
###xml 580 589 580 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g001">Figures 1</xref>
###xml 642 650 642 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g001">Figure 1</xref>
###xml 806 808 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b023">23</xref>
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
Taken together, the findings of a severe inflammatory process in the dnKO mouse colon, which show (i) localization to the cecum and colon (the distal small intestine is not involved; Figures 1B, S1B and unpublished data); (ii) primarily mucosal damage (the muscularis is relatively spared; Figure 2D); (iii) diffuse distribution (no skip areas; Figures 1B and S1B); (iv) numerous crypt abscesses (Figure 2D); (v) marked mucosal regenerative response (Figures 2D and 3D); (vi) loss of goblet cell mucin (Figure 2D); (vii) focal punctate ulcers (no longitudinal ulcers or fissures; Figures 1B and S1B); (viii) lack of prominence of granulomas (Figure 1B); and (ix) no colonic fistulas or strictures, all indicate that the disease process is most representative of ulcerative colitis and not Crohn's disease [23].
###end p 74
###begin title 75
###xml 95 99 <span type="species:ncbi:10090">Mice</span>
Elevated Circulating Proinflammatory Cytokines and Early in Vivo Activation of T Cells in dnKO Mice
###end title 75
###begin p 76
###xml 104 106 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b024">24</xref>
###xml 107 109 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b026">26</xref>
###xml 567 575 548 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g005">Figure 5</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 595 599 <span type="species:ncbi:10090">mice</span>
Human IBD has been associated with elevated proinflammatory cytokines, including IFNgamma and TNFalpha [24-26], and regulation of these types of cytokines is often mediated via signals received through TGFbetaRII and IL-10R2. Therefore, we wanted to determine whether proinflammatory cytokines were significantly altered in dnKO mice during disease. Analysis of circulating IFNgamma, TNFalpha, and IL-6 levels in the serum obtained from 4- to 5-wk-old dnKO mice revealed a striking increase in the concentrations of all three cytokines in comparison to control mice (Figure 5A). Serum from dnKO mice had mean levels of 1,268.5 pg/ml of IFNgamma, 390.9 pg/ml of TNFalpha, and 516.1 pg/ml of IL-6, which respectively represented at least an 18-fold, 6-fold, and 19-fold induction over the highest levels seen in controls.
###end p 76
###begin title 77
###xml 16 20 <span type="species:ncbi:10090">Mice</span>
Colitis in dnKO Mice Is Associated with Elevated Proinflammatory Cytokine Levels and Increased T Cell Activation
###end title 77
###begin p 78
###xml 112 115 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 167 168 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 193 194 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 223 224 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 240 241 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 262 263 241 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 279 280 258 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 297 298 276 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 314 315 293 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 407 408 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 436 457 413 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
(A) Plot of average serum concentrations of IFNgamma, TNFalpha, and IL-6 of 4-5-wk-old WT, dnTGFbetaRII, IL-10R2-/-, and dnKO mice. Shown are the average +/- SEM from n = 10-12 mice/group. The F test results are: INFgamma, F(3,38) = 11.73, p < 0.0001; TNFalpha, F(3,38) = 48.32, p < 0.0001; IL-6, F(3,38) = 18.41, p < 0.0001. Brackets denote all statistically significant differences between two groups; ***p </= 0.0001 as described in Materials and Methods.
###end p 78
###begin p 79
###xml 64 65 64 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 164 166 164 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 170 172 170 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 248 250 248 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 254 256 254 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 366 367 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
(B) A representative example of CD62L versus CD44 profile of CD4+ T cells from the mesenteric (draining) lymph nodes depicting decreased percentages of naive (CD62LhiCD44lo) cells accompanied by increased percentages of effector/memory cells (CD62LloCD44hi) in dnKO mice compared to controls. Similar results were observed in five to seven separate experiments from n = 6-12 mice/group.
###end p 79
###begin p 80
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 42 43 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 52 53 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 193 196 186 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 247 248 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 276 277 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 328 329 315 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 345 346 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 386 387 373 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 403 404 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 440 441 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 457 458 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 491 492 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 508 509 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
(C and D) The percentages of CD4+ IFNgamma+ or IL-17+ cells were determined in the (C) mesenteric (draining) lymph nodes and (D) lamina propria/MALT of 4-5-wk-old mice WT, dnTGFbetaRII, IL-10R2-/-, and dnKO mice. Shown is the average +/- SEM from n = 6-11 mice per group. The F test results are: mesenteric lymph node INFgamma, F(3,33) = 37.52, p < 0.0001; mesenteric lymph node IL-17, F(3,33) = 21.16, p < 0.0001; lamina propria INFgamma, F(3,23) = 20.34, p < 0.0001; lamina propria IL-17, F(3,23) = 7.119, p < 0.0001.
###end p 80
###begin p 81
###xml 43 44 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 116 117 116 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 141 142 141 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
All statistically significant comparisons (p < 0.05) between any two groups are indicated with a bracket. The exact p-value is listed unless p < 0.001 (indicated by ***).
###end p 81
###begin p 82
###xml 298 301 292 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 390 392 384 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 397 399 391 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 462 464 456 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 469 471 463 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 505 506 499 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 514 515 508 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 608 616 602 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g005">Figure 5</xref>
###xml 810 811 801 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b008">8</xref>
###xml 912 913 903 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 921 922 912 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1236 1237 1227 1228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1240 1241 1231 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1254 1263 1245 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050041-sg002">Figure S2</xref>
###xml 1306 1307 1297 1298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1311 1312 1302 1303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1317 1318 1308 1309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1439 1448 1430 1439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050041-sg003">Figure S3</xref>
###xml 1545 1554 1536 1545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050041-sg003">Figure S3</xref>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 844 848 <span type="species:ncbi:10090">mice</span>
###xml 1002 1006 <span type="species:ncbi:10090">mice</span>
###xml 1133 1137 <span type="species:ncbi:10090">mice</span>
###xml 1168 1172 <span type="species:ncbi:10090">mice</span>
###xml 1409 1413 <span type="species:ncbi:10090">mice</span>
###xml 1488 1492 <span type="species:ncbi:10090">mice</span>
###xml 1622 1626 <span type="species:ncbi:10090">mice</span>
We hypothesized that T cells might be responsible for the observed increases in proinflammatory cytokine production. To assess whether the combined loss of both IL-10R2 and TGFbetaRII signaling resulted in a more dramatic alteration in activation status, the phenotypes of WT, dnTGFbetaRII, IL-10R2-/-, and dnKO T cells were examined. At 4-5 wk of age, decreases in the percentages of CD62Lhi CD44lo naive cells were accompanied by increased percentages of CD62Llo CD44hi effector/memory cells in both CD4+ and CD8+ T cell compartments of the mesenteric lymph nodes of dnKO mice as compared to all controls (Figure 5B and unpublished data). Increases in activated and effector/memory cells in dnTGFbetaRII mice as compared to WT controls were also detected, consistent with a previous study by Gorelik et al. [8]. At 3 wk, overtly healthy dnKO mice had similar levels of naive, activated, and effector/memory CD4+ and CD8+ T cells as compared to controls (unpublished data). T cell development in dnKO mice also appeared grossly normal prior to disease as similar CD4 and CD8 profiles were seen in the thymus of overtly healthy dnKO mice. In contrast, disease in dnKO mice was accompanied by thymic involution because of the loss of CD4+CD8+ thymocytes (Figure S2). Additionally, similar percentages of CD4+CD25+Foxp3+ regulatory T cells were detected in the draining lymph node and in the intestines of dnKO mice as compared to controls (Figure S3). Thymic regulatory T cells from these mice also displayed intact inhibitory function in vitro (Figure S3). Together, these data suggest that the T cell compartment in dnKO mice was initially normal, but became rapidly activated during disease.
###end p 82
###begin p 83
###xml 178 186 176 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g005">Figure 5</xref>
###xml 200 201 194 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 205 206 199 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 266 267 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 271 272 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 329 332 320 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 410 411 397 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 415 416 402 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 549 552 527 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 601 602 573 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 606 607 578 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 655 658 624 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 848 849 813 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 853 854 818 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 945 946 906 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 956 957 917 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 961 962 922 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1035 1043 996 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g005">Figure 5</xref>
###xml 1304 1305 1249 1250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 669 673 <span type="species:ncbi:10090">mice</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
###xml 871 875 <span type="species:ncbi:10090">mice</span>
###xml 993 997 <span type="species:ncbi:10090">mice</span>
###xml 1156 1160 <span type="species:ncbi:10090">mice</span>
###xml 1343 1347 <span type="species:ncbi:10090">mice</span>
Next we determined if T cell effector function was altered in dnKO mice by examination of cytokine production. At >/=4 wk of age, dnKO mice had significantly higher percentages (Figure 5C) of IFNgamma+ CD4+ T cells over all controls and enhanced percentages of IL-17+ CD4+ T cells compared to WT and dnTGFbetaRII, but not IL-10R2-/- mice, in the mesenteric lymph nodes. Additionally, the percentage of TNFalpha+ CD4+ cells was elevated in both dnTGFbetaRII (32.6 +/- 2.4%) and dnKO (36.2 +/- 3.4%) mice as compared to WT (23.8% +/- 2.5%) and IL-10R2-/- (22.4% +/- 4.1%) controls. Increases in IFNgamma+ CD8+ T cells were also seen in dnTGFbetaRII, IL-10R2-/-, and dnKO mice in comparison to WT mice (unpublished data). Isolation of T cells from the lamina propria/MALT of the cecum and colon revealed a significantly elevated percentage of IFNgamma+ CD4+ T cells in dnKO mice at the site of inflammation. In contrast, the percentages of TNFalpha+ and IL-17+ CD4+ T cells in the colons of dnKO mice were similar or lower than controls (Figure 5D and unpublished data). Elevated levels of IFNgamma and TNFalpha were also detected in colon explants from dnKO mice as compared to controls (unpublished data). Because TNFalpha was increased in both the serum and colon explants but the percentages of TNFalpha+ T cells were similar to dnTGFbetaRII mice, this suggests that other cells (e.g., macrophages) are generating more of this particular cytokine. Together these data showed that multiple genetic hits to immune regulation signaling pathways resulted in significant exacerbation of T cell activation and effector function.
###end p 83
###begin title 84
###xml 8 9 8 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 41 44 41 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 45 49 <span type="species:ncbi:10090">Mice</span>
dnKO CD4+ T Cells Transfer Disease in RAG-/- Mice
###end title 84
###begin p 85
###xml 137 138 137 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b027">27</xref>
###xml 196 197 196 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 250 253 247 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 295 298 292 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 630 631 627 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 641 649 638 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g006">Figure 6</xref>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
To examine directly the role of T cells in the induction of ulcerative colitis in the dnKO mice, we utilized the established model of CD4+ T cell transfer into immunodeficient recipients [27]. CD4+ T cells were isolated from WT, dnTGFbetaRII, IL-10R2-/-, and dnKO mice and transferred to B6.RAG1-/- mice. Recipient mice were humanely killed and their colons analyzed at either 5 wk post-transfer or upon loss of >20% of their initial body weight, whichever occurred first. Weight loss of >20% within 5 wk of transfer was observed in four of six mice in the dnKO T cell recipient group but none of the animals in the other groups (p < 0.001; Figure 6A).
###end p 85
###begin title 86
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 83 86 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 35 39 <span type="species:ncbi:10090">Mice</span>
###xml 87 91 <span type="species:ncbi:10090">Mice</span>
Transferred CD4+ T Cells from dnKO Mice Induce Fulminant Ulcerative Colitis in RAG1-/- Mice
###end title 86
###begin p 87
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 79 82 64 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 108 109 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 148 151 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
CD4+ T cells were purified from approximately3-wk-old WT, dnTGFbetaRII, IL-10R2-/-, and dnKO mice and 2 x 106 cells were transferred IP into B6.RAG1-/- hosts.
###end p 87
###begin p 88
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 82 83 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 110 111 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 125 128 122 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 137 138 134 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 159 160 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 584 585 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
(A) Weights were recorded for mice that had received CD4+ T cells from WT (black, n = 4), dnTGFbetaRII (blue, n = 6), IL-10R2-/- (green, n = 6), or dnKO (red, n = 6) mice. Shown for each group is the percent initial weight of individual mice from three separate experiments. The upward arrow indicates individual mice that were humanely killed for analysis when their weight reached </= 80% of their maximal weight (dashed lines). Analysis using the Kaplan-Meier method showed the difference between groups of mice reaching this endpoint of weight loss was statistically significant (p < 0.001, df = 3, log-rank test).
###end p 88
###begin p 89
###xml 397 398 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 424 425 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 440 441 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 469 470 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 486 487 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 516 517 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 533 534 533 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 553 554 553 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 570 571 570 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 670 671 670 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 744 745 744 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 769 770 769 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 839 840 839 840 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 925 926 922 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 369 374 <span type="species:ncbi:10090">mouse</span>
(B) Whole mount photographs of the cecum, ascending colon, descending colon, and rectum were scored in a blinded fashion on a 0-3 scale. 0, normal; 1, focal ulcers present; 2, ulcers and diffuse, mild mucosal thickening; and 3, ulcers and diffuse, severe mucosal thickening. The bars represent the average whole-mount score, with each circle representing an individual mouse described in (A). The F test results are: cecum, F(3,18) = 8.07, p = 0.0013; ascending colon, F(3,18) = 17.93, p < 0.0001; descending colon, F(3,18) = 7.720, p = 0.0016; rectum, F(3,18) = 14.39, p < 0.0001. All statistically significant differences (using Bonferroni's multiple comparison test; p < 0.05) between any two groups were indicated with a bracket. The exact p-value is listed unless p < 0.001 (indicated by ***). Scores for recipients receiving dnKO CD4+ T cells were significantly higher than those receiving either WT or dnTGFbetaRII CD4+ T cells in the ascending colon, descending colon, and rectum.
###end p 89
###begin p 90
###xml 312 315 310 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 338 339 336 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 379 380 377 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 415 416 413 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 432 433 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 461 462 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 478 479 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 510 511 508 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 527 528 525 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 560 561 558 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 577 578 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 677 678 675 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 750 751 748 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 775 776 773 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 832 833 830 831 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1109 1110 1107 1108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 316 320 <span type="species:ncbi:10090">mice</span>
###xml 805 809 <span type="species:ncbi:10090">Mice</span>
(C) The height and width of the crypts in the descending colon and rectum of HE stained tissue samples were analyzed to measure epithelial hyperplasia and crypt drop out of the mice described in (A). The bar graphs represent the average crypt height or width +/- SEM in the descending colon or rectum from B6RAG1-/- mice that received CD4+ T cells from the indicated donors. The F test results are: DC crypt width, F(3,18) = 5.061, p = 0.0102; DC crypt height, F(3,18) = 20.23, p < 0.0001; rectum crypt width, F(3,18) = 13.82, p < 0.0001; rectum crypt height, F(3,18) = 23.58, p < 0.0001. All statistically significant differences (using Bonferroni's multiple comparison test; p < 0.05) between any two groups are indicated with a bracket. The exact p-value is listed unless p < 0.001 (indicated by ***). Mice that received dnKO CD4+ T cells had statistically significant increases in crypt height in the descending colon and rectum compared to all controls and wider crypts in the rectum compared to all controls. Significant increases in the width of descending colon crypts in recipients receiving dnKO CD4+ T cells as compared to recipients receiving WT or dnTGFbetaRII were also observed.
###end p 90
###begin p 91
###xml 220 223 217 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 238 246 235 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g006">Figure 6</xref>
###xml 252 253 249 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g006">6</xref>
###xml 277 278 274 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 447 448 444 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 494 497 488 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 514 522 508 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g006">Figure 6</xref>
###xml 723 724 717 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 768 769 762 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 425 429 <span type="species:ncbi:10090">mice</span>
###xml 841 845 <span type="species:ncbi:10090">mice</span>
Gross and histologic examination of colons from recipient mice showed a trend whereby transfer of T cells from dnKO donors produced more severe colitis as compared to transfer of T cells from either dnTGFbetaRII, IL-10R2-/- or WT donors (Figure 6B and 6C). Transfer of dnKO CD4+ T cells induced a significant increase in the crypt height and width in the rectum as well as crypt height in the descending colon as compared to mice that received CD4+ T cells from the WT, dnTGFbetaRII, or IL-10R2-/- control groups (Figure 6C). Because crypt height and width reflected the amount of hyperplasia and crypt dropout that had occurred within the colon, these measurements were indicative of severe colitis induced by the dnKO CD4+ T cells. These studies demonstrate that CD4+ T cells were directly involved in the induction of colitis in the dnKO mice.
###end p 91
###begin title 92
###xml 82 86 <span type="species:ncbi:10090">Mice</span>
Neutralization of IFNgamma and TNFalpha Significantly Ameliorates Disease in dnKO Mice
###end title 92
###begin p 93
###xml 547 555 527 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g007">Figure 7</xref>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
###xml 794 798 <span type="species:ncbi:10090">mice</span>
###xml 911 915 <span type="species:ncbi:10090">mice</span>
Since IFNgamma and TNFalpha are present at elevated levels in dnKO mice during disease, we neutralized these cytokines either singly or in combination to determine if doing so would limit disease. Well-characterized antibodies against IFNgamma, TNFalpha, or both were administered at 2 and 3 wk of age in dnKO mice prior to disease assessment at 4 wk. Anti-IFNgamma treatment alone significantly diminished loss of crypts, goblet cells, and surface epithelial cell height, but did not affect epithelial hyperplasia as compared to isotype control (Figure 7). In contrast, mice given anti-TNFalpha treatment alone did not have any significant alterations in colitis induction. Interestingly, neutralization of both IFNgamma and TNFalpha resulted in even greater amelioration of pathology in dnKO mice than single therapy alone, including significantly decreased epithelial hyperplasia. Therefore, colitis in dnKO mice is partly mediated by excessive IFNgamma and TNFalpha production, and combination therapy to neutralize these cytokines significantly diminished most aspects of pathology.
###end p 93
###begin title 94
###xml 32 36 <span type="species:ncbi:10090">Mice</span>
Amelioration of Colitis in dnKO Mice Through Simultaneous Neutralization of IFNgamma and TNFalpha
###end title 94
###begin p 95
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
(A) HE-stained sections of the rectums of dnKO mice treated with neutralizing antibodies to inflammatory cytokines. Colons from dnKO mice injected IP with 1 mg of neutralizing antibodies against IFNgamma, TNFalpha, IFNgamma + TNFalpha, or an isotype control (anti-PIP) at 2 and 3 wk of age were harvested at 4 wk of age.
###end p 95
###begin p 96
###xml 73 77 <span type="species:ncbi:10090">mice</span>
(B-F) Quantitative morphometric analysis of the histopathology from dnKO mice treated with anti-PIP (isotype control), anti-IFNgamma, anti-TNFalpha, or a combination of anti-IFNgamma and anti-TNFalpha is shown. Crypt loss/dropout was measured by examining (B) the number of crypts per field (a field, 870 mum) and (C) crypt width. Epithelial proliferation was measured by (D) crypt height taken from the base of the crypt to the basal side of the surface epithelial cells.
###end p 96
###begin p 97
(E and F) The ratio of goblet cells/epithelial cells per crypt (E) and surface epithelial heights (F) were quantified to examine goblet cell loss and barrier changes.
###end p 97
###begin p 98
###xml 57 58 55 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 83 84 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 106 107 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 123 124 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 139 140 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 156 157 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 172 173 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 189 190 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 205 206 203 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 222 223 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 242 243 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 259 260 257 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 359 360 357 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 433 434 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 458 459 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Shown for all measurements are the averages +/- SEM from n = 5 mice per group. The F test results are (B) F(3,17) = 7.627, p = 0.0019; (C) F(3,17) = 7.467, p = 0.0021; (D) F(3,17) = 4.326, p = 0.0194; (E) F(3,17) = 11.45, p = 0.0002; and (F) F(3,17) = 3.664, p = 0.0334. All statistically significant differences (using Bonferroni's multiple comparison test; p < 0.05) between any two groups were indicated with a bracket. The exact p-value is listed unless p < 0.001 (indicated by ***).
###end p 98
###begin title 99
###xml 78 82 <span type="species:ncbi:10090">Mice</span>
Treatment with Broad-Spectrum Antibiotics Completely Inhibits Disease in dnKO Mice
###end title 99
###begin p 100
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b028">28</xref>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b029">29</xref>
###xml 947 949 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b030">30</xref>
###xml 1054 1062 1054 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g008">Figure 8</xref>
###xml 1065 1066 1065 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1202 1205 1199 1202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1246 1254 1243 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g008">Figure 8</xref>
###xml 1437 1438 1434 1435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1448 1456 1445 1453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g008">Figure 8</xref>
###xml 24 30 <span type="species:ncbi:10090">murine</span>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
###xml 747 751 <span type="species:ncbi:10090">mice</span>
###xml 1019 1023 <span type="species:ncbi:10090">mice</span>
###xml 1134 1138 <span type="species:ncbi:10090">mice</span>
###xml 1273 1277 <span type="species:ncbi:10090">mice</span>
Studies in a variety of murine models have shown an important role for intestinal bacteria in inducing colitic disease [28]. At 2 wk of age, the intestines of dnKO mice appeared normal both macroscopically and microscopically (unpublished data). This observation indicated that general intestinal architecture development in these mice was not perturbed at this time. Disease induction was rapid and could be detected by 3 wk of age, a time commensurate with known changes in the microbial ecology of the mammalian intestine that occur at the weaning-suckling transition [29]. To examine whether bacteria influence disease development in the dnKO model, we treated mice with broad-spectrum antibiotics in drinking water. Beginning at 24 d of age, mice received drinking water containing high-dose ciprofloxacin and metronidazole, two commonly used antibiotics that are broadly active against aerobic and anaerobic bacterial species, respectively [30]. In striking contrast to untreated animals, antibiotic-treated dnKO mice exhibited 100% 45-d survival (Figure 8A; p < 0.0001). We were thus able to compare the growth of treated dnKO mice with treated littermate controls (WT, dnTGFbetaRII, and IL-10R2-/- combined) over a 3-wk treatment period (Figure 8B). Both groups of mice showed weight gain over the course of the experiment. No statistically significant difference in weight gain was observed between the dnKO and control groups (p = 0.105; Figure 8C).
###end p 100
###begin title 101
###xml 30 34 <span type="species:ncbi:10090">Mice</span>
Inhibition of Colitis in dnKO Mice by Broad-spectrum Antibiotic Treatment
###end title 101
###begin p 102
###xml 42 43 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 172 173 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 411 412 409 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
(A) 45-d survival of untreated dnKO mice (n = 19; 45-d survival = 10.5%; median survival = 35 d) and dnKO mice receiving metronidazole and ciprofloxacin in drinking water (n = 8; 45-d survival = 100%). Individual mice died or were humanely killed when their weight reached </= 70% of maximal weight. Survival was analyzed by the Kaplan-Meier method, and statistical significance of difference between groups is p < 0.0001, by log-rank test. Upward arrow, antibiotic treatment begun at age 24 d.
###end p 102
###begin p 103
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 101 102 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 183 184 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 212 213 209 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 229 232 226 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 574 575 566 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 648 649 640 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
(B and C) Weight gain of antibiotic-treated mice (n = 2 WT, n = 3 IL-10R-/-, n = 4 dnTGFbetaRII, and n = 7 dnKO) plotted individually (B) or as mean weights (C) of treated dnKO mice (n = 7) and treated controls (n = 9; WT, IL-10R-/-, and dnTGFbetaRII combined) +/- SEM. Data were pooled from three separate experiments using dnKO and littermate controls. To account for the longitudinal nature of the data, analysis of weight change over the course of treatment was performed using generalized estimating equations. The mice gained weight over the course of the experiment (p < 0.001), and the dnKO and control groups did not differ significantly (p = 0.105).
###end p 103
###begin p 104
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
###xml 145 150 <span type="species:ncbi:10090">mouse</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
(D) Representative images of HE stained sections of rectums from an untreated dnKO mouse humanely killed at >/= 4 wk, an antibiotic-treated dnKO mouse, and an antibiotic-treated WT mice killed at 45 d of age are shown at low power (bars in [C-E], 200 mum).
###end p 104
###begin p 105
###xml 85 86 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 124 125 116 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 146 147 135 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 160 163 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 165 166 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 183 184 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 365 366 350 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 432 440 417 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g005">Figure 5</xref>
###xml 468 469 453 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
###xml 345 350 <span type="species:ncbi:10090">mouse</span>
###xml 512 517 <span type="species:ncbi:10090">mouse</span>
(E) Serum concentrations of IFNgamma, TNFalpha, and IL-6 in individual untreated WT (n = 3) mice and antibiotic-treated WT (n = 1), dnTGFbetaRII (n = 2), IL-10R-/- (n = 2), and dnKO (n = 5) mice measured at 5-6 wk. All concentrations were below the limit of detection (<20 pg/ml) except for low levels of IFNgamma in one antibiotic-treated dnKO mouse (54.8 pg/ml). 1Ranges of cytokine concentrations from the experiment depicted in Figure 5A are shown for comparison. 2Indicates exclusion of outlier values: one mouse had 4,493 pg/ml IFNgamma, and one had 75 pg/ml IL-6.
###end p 105
###begin p 106
###xml 306 314 306 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g008">Figure 8</xref>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
Consistent with survival and growth observations, gross and histologic examination of intestines from all antibiotic-treated dnKO mice aged 45-48 d revealed no inflammation, mucosal thickening, or ulceration throughout the cecum and colon, with dnKO intestines appearing essentially identical to controls (Figure 8D and unpublished data). The quantitative morphometric measures of inflammation described previously did not differ significantly between treated dnKO mice and controls (unpublished data).
###end p 106
###begin p 107
###xml 232 240 232 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g005">Figure 5</xref>
###xml 389 397 381 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g008">Figure 8</xref>
###xml 475 478 464 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 508 517 497 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g005">Figures 5</xref>
###xml 523 524 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050041-g008">8</xref>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
###xml 656 660 <span type="species:ncbi:10090">mice</span>
In accordance with the absence of inflammation and mucosal barrier damage, analysis of serum from antibiotic-treated mice revealed near-complete abrogation of proinflammatory cytokine production. In contrast to untreated dnKO mice (Figure 5A), mice on antibiotics had undetectable levels of TNFalpha and IL-6, and IFNgamma was detectable at low levels in only one of five animals assayed (Figure 8E). Antibiotics also decreased cytokine production in dnTGFbetaRII and IL-10R2-/- mice to undetectable levels (Figures 5A and 8E). Collectively, these results demonstrate that broad-spectrum antibiotic treatment completely inhibits ulcerative colitis in dnKO mice.
###end p 107
###begin title 108
Discussion
###end title 108
###begin p 109
###xml 439 440 439 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
In this report, we demonstrate multiple genetic deficiencies in immune regulation result in fulminant ulcerative colitis that is distinct from and more severe than the disease induced by either of the single deficiencies alone. In addition to documenting these pathologic findings, we further show that disease in dnKO mice is characterized by elevated proinflammatory cytokines, can be induced in recipient animals by transfer of dnKO CD4+ T cells, is responsive to combined neutralization of IFNgamma and TNFalpha, and can be completely inhibited through treatment with high-dose oral ciprofloxacin and metronidazole.
###end p 109
###begin p 110
###xml 184 185 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b007">7</xref>
###xml 186 187 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b009">9</xref>
###xml 188 190 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b031">31</xref>
###xml 191 193 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b035">35</xref>
###xml 307 310 298 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 582 585 570 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 652 655 640 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 890 892 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b010">10</xref>
###xml 893 895 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b011">11</xref>
###xml 162 168 <span type="species:ncbi:10090">murine</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
###xml 656 660 <span type="species:ncbi:10090">mice</span>
Previous work has shown that the inhibitory cytokines IL-10 and TGFbeta, both known to control immune homeostasis, are associated with protection from colitis in murine models of IBD [7-9,31-35]. We crossed dnTGFbetaRII mice, which have significantly attenuated TGFbetaRII signaling in T cells, with IL-10R2-/- mice. The resulting dnKO mice showed a highly reproducible, diffuse, and severe ulcerative colitis that occurred in a predictable time frame. At the same time point at which dnKO mice developed severe disease and died, all controls including WT, dnTGFbetaRII, and IL-10R2-/- mice demonstrated little to no pathology. Similarly, work in IL-10-/- mice has demonstrated differential colitis severity in a C3H/HeJBir versus a C57BL/6J background and linked the differences to a region on Chromosome 3, referred to as the cytokine deficiency-induced colitis susceptibility 1 (Cdcs1) [10,11]. These findings all support the idea that IBD is a complex disease influenced by multiple interacting host genetic factors.
###end p 110
###begin p 111
###xml 525 527 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b036">36</xref>
###xml 528 530 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b037">37</xref>
###xml 1010 1012 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b031">31</xref>
###xml 1100 1101 1091 1092 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1508 1509 1490 1491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1522 1524 1504 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b038">38</xref>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 1128 1132 <span type="species:ncbi:10090">mice</span>
Because both dnTGFbetaRII and IL-10R2 signaling are important for various aspects of immune regulation, the disease observed in dnKO mice was likely due to a culmination of several dysregulated parameters. The recent generation of T cell specific TGFbetaRII knockout mice revealed that this defect alone was sufficient to induce rapid, multiorgan autoimmunity. These mice demonstrated alterations in Th1 T cell differentiation, NKT cell development, and impaired maintenance, but not generation, of Foxp3 regulatory T cells [36,37]. Similarly, in dnKO mice, regulatory T cells were present at similar percentages to controls, suggesting that regulatory T cell development was also intact in these mice. Furthermore, dnKO T regulatory cells were able to inhibit naive T cell proliferation in vitro, suggesting that they still are able to function in this context. Regulation of a T cell transfer model of colitis has previously been demonstrated to depend on TGFbeta responsiveness by pathogenic naive T cells [31], emphasizing the importance of this cytokine in disease inhibition. We showed that CD4+ T cells from dnTGFbetaRII mice could also transfer disease, but found that the additional loss of IL-10R2 signaling increased the severity of disease above that conferred by cells in which only TGFbetaRII signaling was disrupted. These studies, however, did not address whether the loss of IL-10R2 and TGFbetaRII signaling caused dysregulation of the naive or regulatory T cell subsets found within the CD4+ population [38].
###end p 111
###begin p 112
###xml 252 253 249 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 298 300 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b012">12</xref>
###xml 301 303 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b014">14</xref>
###xml 304 306 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b039">39</xref>
###xml 307 309 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b042">42</xref>
###xml 396 399 393 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 529 530 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b007">7</xref>
###xml 558 561 555 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 596 599 593 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 811 813 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b043">43</xref>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
###xml 600 604 <span type="species:ncbi:10090">mice</span>
In addition to impaired TGFbetaRII signaling, IL-10R2 signaling was completely absent in dnKO mice. As a result, these mice were unresponsive to IL-10, which normally inhibits antigen-presenting cell function and may play a role in converting naive CD4+ T cells to those with regulatory potential [12,14,39-42]. The importance of IL-10 in regulation of colitis was initially demonstrated in IL-10-/- mice that developed spontaneous enterocolitis marked by crypt abnormalities, epithelial hyperplasia, and leukocytic infiltrates [7]. The generation of IL-10R2-/- mice recapitulated data from IL-10-/- mice in that they also spontaneously developed colitis marked by epithelial hyperplasia and leukocytic infiltrates. Interestingly, IL-10 has also been implicated in contributing to epithelial barrier integrity [43], which would be a critical aspect in limiting intestinal mucosal inflammation.
###end p 112
###begin p 113
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b044">44</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b045">45</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b046">46</xref>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b045">45</xref>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b047">47</xref>
###xml 762 765 762 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 856 859 856 859 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 866 867 866 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b007">7</xref>
###xml 868 869 868 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b009">9</xref>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 361 366 <span type="species:ncbi:9606">human</span>
###xml 371 379 <span type="species:ncbi:9606">patients</span>
###xml 766 770 <span type="species:ncbi:10090">mice</span>
###xml 860 864 <span type="species:ncbi:10090">mice</span>
Because the IL-10R2 is also a redundant receptor for other cytokines, including IL-22, IL-26, IL-28, and IL-29 [44], the effects of these cytokines on colitis development in dnKO mice could not be ruled out. While little is known about the relevance of most of these cytokines in the context of intestinal immunity, increased levels of IL-22 have been noted in human IBD patients, and IL-22 has also been demonstrated to induce IL-10 expression by colon epithelial cell lines [45,46]. However, abrogation of signaling in these cells may be beneficial, as IL-22 has also been shown to induce production of proinflammatory cytokines by colonic subepithelial myofibroblasts and intestinal epithelial cells [45,47]. Additionally, previous characterization of IL-10R2-/- mice did not reveal an increased disease severity compared to what was described for IL-10-/- mice [7,9]. With the given caveat that there may have been differences in enteric flora, the data from these studies suggest that IL-10, but not the other redundant IL-10R2 cytokines, plays the predominant role in colitis induction and exacerbation.
###end p 113
###begin p 114
###xml 235 237 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b012">12</xref>
###xml 238 240 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b016">16</xref>
###xml 349 351 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b024">24</xref>
###xml 352 354 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b026">26</xref>
###xml 373 374 370 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 483 485 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b024">24</xref>
###xml 711 713 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b048">48</xref>
###xml 828 830 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b049">49</xref>
###xml 831 833 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b052">52</xref>
###xml 338 343 <span type="species:ncbi:9606">human</span>
###xml 401 409 <span type="species:ncbi:9606">patients</span>
###xml 599 607 <span type="species:ncbi:9606">patients</span>
###xml 727 733 <span type="species:ncbi:10090">murine</span>
###xml 844 848 <span type="species:ncbi:10090">mice</span>
###xml 1145 1149 <span type="species:ncbi:10090">mice</span>
In addition to potential alterations in APC function, epithelial barrier integrity, and T regulatory-mediated suppression, a major function attributed to both IL-10 and TGFbeta is the inhibition of proinflammatory cytokine production [12-16]. Excessive production of proinflammatory cytokines has been implicated as a potential factor in human IBD [24-26]. For example, CD4+ lamina propria cells from patients with Crohn's disease produced increased levels of IFNgamma and TNFalpha [24]. Furthermore, neutralization of TNFalpha via administration of infliximab resulted in clinical benefits for IBD patients and a variety of other such biologic agents are in various stages of development and clinical testing [48]. Studies in murine colitis models have also shown reduced pathology upon neutralization of IFNgamma or TNFalpha [49-52]. In dnKO mice, impairment or loss of both TGFbetaRII and IL-10R2 signaling resulted in intestinal pathology that was associated with dramatic increases in both T cell activation and IFNgamma, TNFalpha, and IL-6 levels. Depletion of IFNgamma and TNFalpha decreased the extent of pathology seen in 4-wk-old dnKO mice as compared to controls. While anti-IFNgamma treatment alone partially ameliorated disease, anti-TNFalpha treatment alone had little to no impact on intestinal pathology. Interestingly, significant reductions in epithelial hyperplasia were only detected when the two treatments were combined, suggesting that in the dnKO model these two cytokines have redundant roles in inducing hyperplasia. Our data therefore suggest that treatment regimens that effectively neutralize multiple proinflammatory cytokines could result in more successful clinical responses.
###end p 114
###begin p 115
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b053">53</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b055">55</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b056">56</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b057">57</xref>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b058">58</xref>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b059">59</xref>
###xml 838 840 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b055">55</xref>
###xml 918 920 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b060">60</xref>
###xml 921 923 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b061">61</xref>
###xml 177 182 <span type="species:ncbi:9606">human</span>
###xml 194 200 <span type="species:ncbi:10090">murine</span>
###xml 367 372 <span type="species:ncbi:9606">human</span>
###xml 1030 1034 <span type="species:ncbi:10090">mice</span>
###xml 1180 1184 <span type="species:ncbi:10090">mice</span>
In recent years the role of IL-12 versus IL-23 in chronic inflammation has been reevaluated upon the realization that both cytokines share the IL-12p40 subunit [53-55]. In both human trials and murine models of colitis, neutralization of the IL-12p40 subunit resulted in decreased pathology [56,57]. Recently, a mutation in the IL-23R has been negatively linked with human IBD, suggesting that reduced signaling through this receptor protects against disease [58]. Additionally, a study by Yen et al. has indicated a role for IL-23, rather than IL-12, in the induction of colitis due to its ability to promote IL-17 production [59]. However, the proinflammatory effects of IL-23 are not necessarily restricted to its effects on IL-17 producing cells as IL-23 can increase proliferation and IFNgamma production by effector/memory T cells [55] and has been demonstrated to also increase Th1 responses in colitis models [60,61]. Because IL-17 secretion was detected in the supernatants of colon explants (unpublished data) from dnKO mice, albeit at lower levels compared to IFNgamma and TNFalpha production, IL-17 and/or IL-23 may account for the residual pathology observed in dnKO mice after neutralization of both IFNgamma and TNFalpha. Regardless, results from our study and others would suggest that large perturbations in immune homeostasis through production of excessive Th1, Th17, or Th2 cytokines all have the ability to cause intestinal pathology.
###end p 115
###begin p 116
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b028">28</xref>
###xml 217 220 217 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b062">62</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b022">22</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b063">63</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b064">64</xref>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b065">65</xref>
###xml 54 60 <span type="species:ncbi:10090">murine</span>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
###xml 449 455 <span type="species:ncbi:10090">murine</span>
###xml 864 868 <span type="species:ncbi:10090">mice</span>
Several overlapping lines of evidence, primarily from murine models, point to involvement of enteric bacteria in inducing IBD (reviewed in [28]). For example, intestinal pathology in a number of models including IL-10-/- mice was diminished in germ-free settings [62]. Similarly, colonic inflammation due to DSS-induced injury has been shown to be reduced in germ-free and antibiotic-treated mice [22,63]. Experiments employing antibiotics to treat murine models of spontaneous colitis have demonstrated variable degrees of success depending on the animal model and the antibiotics used (e.g., [64,65]). We chose to employ two orally delivered antibiotics at high dosages: ciprofloxacin, which broadly targets aerobic bacteria, and metronidazole, which is active against anaerobic organisms. Antibiotic treatment resulted in complete inhibition of disease in dnKO mice as demonstrated by survival, weight gain equivalent to controls, absence of macroscopic and microscopic signs of colitis, and near-complete abrogation of proinflammatory cytokine production. These findings dramatically demonstrate that intestinal microbes are required for disease induction in this model of ulcerative colitis.
###end p 116
###begin p 117
###xml 277 279 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b048">48</xref>
###xml 818 820 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b030">30</xref>
###xml 821 823 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b066">66</xref>
###xml 824 826 816 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b067">67</xref>
###xml 917 919 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b048">48</xref>
###xml 920 922 912 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b068">68</xref>
###xml 923 925 915 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050041-b069">69</xref>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 532 540 <span type="species:ncbi:9606">patients</span>
###xml 873 881 <span type="species:ncbi:9606">patients</span>
As discussed previously, current efforts at developing treatments for various forms of IBD, particularly ulcerative colitis, have focused extensively on devising costly new biologic agents, many of which act by specifically targeting cytokines including TNFalpha and IFNgamma [48]. Our results demonstrate that neutralization of these cytokines, particularly in combination, also produced significant amelioration of colitis in dnKO mice. Although antibiotics, including ciprofloxacin and metronidazole, are sometimes used to treat patients with IBD, research regarding their efficacy remains inadequate. Current clinical consensus holds that they are useful in managing septic complications of IBD and certain aspects of Crohn's disease. However, their utility in ulcerative colitis has not been adequately assessed [30,66,67], and recommendations vary regarding usage in patients with fulminant ulcerative colitis [48,68,69]. We know of no large, blinded, controlled clinical studies examining combined metronidazole and ciprofloxacin treatment in ulcerative colitis. Our results suggest that carefully controlled studies examining the benefits of combined ciprofloxacin and metronidazole in ulcerative colitis may be appropriate.
###end p 117
###begin p 118
###xml 850 855 <span type="species:ncbi:9606">human</span>
Overall, our studies support the hypothesis that multiple genetic hits to immune regulation have the ability to produce the most severe forms of IBD. While impairment of either TGFbetaRII or IL-10R2 signaling alone was sufficient to cause some aspects of disease, the extent of pathology was significantly increased once these deficiencies were compounded. Our data demonstrate that the mechanism was at least in part due to uncontrolled T cell activation resulting in increased proinflammatory cytokine production. We further show that the inciting stimulus for this immune activation is microbial in origin. We propose that this model will be useful in the future to evaluate the mechanism of loss/attenuation of specific mucosal barrier components (e.g., goblet cells, surface enterocyte maturation, and epithelial stem cells) that also occurs in human ulcerative colitis, to evaluate combinatorial therapies directed against the numerous proinflammatory cytokines that are elicited by disregulated leukocytes, and to elucidate the mechanisms by which enteric microbes trigger disease.
###end p 118
###begin title 119
Supporting Information
###end title 119
###begin title 120
###xml 48 51 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 52 56 <span type="species:ncbi:10090">Mice</span>
###xml 165 169 <span type="species:ncbi:10090">Mice</span>
Intestinal Pathology in dnTGFbetaRII and IL-10R2-/- Mice Develops More Slowly and Has a More Variable and Focal Pattern Than the Rapid, Diffuse Disease Seen in dnKO Mice
###end title 120
###begin p 121
###xml 45 48 42 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 220 223 214 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
Ceca and colons from dnTGFbetaRII and IL-10R2-/- mice were isolated at 3-4 mo of age. (A) Mucosal whole-mount photomicrographs of the gross morphology of the descending colon/rectum region of two dnTGFbetaRII and IL-10R2-/- mice are shown. Yellow dashed line outlines focal ulcerations.
###end p 121
###begin p 122
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
(B) The cecum and entire colon of four individual 3- to 3.5-mo-old IL-10R2-/- mice and two 4-5-wk-old dnKO mice are shown. Yellow dashed line outlines focal ulcerations; red dashed line outlines diffuse mucosal thickening; pink asterisk indicates ileal-cecal junction.
###end p 122
###begin p 123
(8.2 MB TIF)
###end p 123
###begin p 124
Click here for additional data file.
###end p 124
###begin title 125
###xml 77 81 <span type="species:ncbi:10090">Mice</span>
Thymic T Cell Development Is Not Obviously Perturbed in Overtly Healthy dnKO Mice
###end title 125
###begin p 126
###xml 87 90 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
(A) Representative CD4 versus CD8 thymic profiles of 3-wk-old WT, dnTGFbetaRII, IL-10R2-/-, and dnKO mice, which were overtly healthy, are shown. This is representative of three to four separate experiments with four to eight mice per group.
###end p 126
###begin p 127
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 199 202 190 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
(B) Depletion of thymic CD4+CD8+ cells is shown in >/=4-wk-old diseased dnKO mice. The average +/- standard error of the mean (SEM) of the thymic cellularity for >/=4-wk-old WT, dnTGFbetaRII, IL-10R2-/-, and dnKO is shown.
###end p 127
###begin p 128
###xml 75 76 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 103 104 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 129 130 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 239 240 239 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
These results are generated from three to seven separate experiments, with n = 7-8 mice per group. The F test result for (B) is: F(3,26) = 43.14, p = 0.0001. Brackets denote statistically significant differences between the two groups; ***p </= 0.0001.
###end p 128
###begin p 129
(591 KB TIF)
###end p 129
###begin p 130
Click here for additional data file.
###end p 130
###begin title 131
###xml 39 43 <span type="species:ncbi:10090">Mice</span>
Regulatory T cells Are Present in dnKO Mice
###end title 131
###begin p 132
###xml 66 69 63 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 222 223 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
(A) Cells from mesenteric lymph nodes of WT, dnTGFbetaRII, IL-10R2-/-, and dnKO mice were isolated and stained for CD4, CD25, and Foxp3 expression. Shown are representative plots of CD25 versus Foxp3 staining, gated on CD4+ T cells.
###end p 132
###begin p 133
###xml 26 27 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 156 159 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
(B) The percentages of CD4+ CD25+ Foxp3+ found in the lamina propria of the pooled cecum, descending colon, and rectum of 4-wk-old WT, dnTGFbetaRII, IL-10R2-/-, and dnKO mice is shown. Each bar represents the average +/- SEM from three separate experiments.
###end p 133
###begin p 134
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 95 98 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 172 173 169 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 179 181 176 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
(C) CD4+ CD8- CD25+ regulatory T cells derived from thymi of 3-wk-old WT, dnTGFbetaRII, IL-10R2-/-, and dnKO mice, which were overtly healthy, were incubated with naive CD4+CD45RBhi T cells at a 1:1 ratio and stimulated with irradiated antigen-presenting cells and anti-CD3.
###end p 134
###begin p 135
###xml 199 200 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 223 224 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 240 241 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 260 261 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 276 277 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Shown is the average +/- SEM of the percent inhibition of proliferation induced by T regulatory cells derived from the indicated source. The results are generated from >/=3 separate experiments. The F test results are (B), F(3,16) = 2.104, p = 0.14 (ns); (C), F(3,14) = 2.15, p = 0.14 (ns).
###end p 135
###begin p 136
(1.4 MB TIF)
###end p 136
###begin p 137
Click here for additional data file.
###end p 137
###begin p 138
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 174 179 <span type="species:ncbi:10090">mouse</span>
We thank Genentech for the CRF2-4-/- (IL-10R2-/-) mice; Robert Schreiber for the neutralizing antibodies; Darren Kreamalmeyer for technical assistance and maintenance of the mouse colony; John Liu and Sarah Brown for assistance with intestinal tissue processing; Suellen Greco for helpful discussions about design of the antibiotic regimen; Jerri Smith and Donna Thompson for assistance in manuscript preparation; and Jason Doherty for help with the figure preparation.
###end p 138
###begin title 139
Abbreviations
###end title 139
###begin p 140
###xml 22 25 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
dnTGFbetaRII x IL-10R2-/-
###end p 140
###begin p 141
###xml 22 25 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
dnTGFbetaRII x IL-10R2+/-
###end p 141
###begin p 142
hematoxylin and eosin
###end p 142
###begin p 143
inflammatory bowel disease
###end p 143
###begin p 144
mucosally associated lymphoid tissue
###end p 144
###begin p 145
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
IL-10R2+/-
###end p 145
###begin title 146
References
###end title 146
###begin article-title 147
Unravelling the pathogenesis of inflammatory bowel disease
###end article-title 147
###begin article-title 148
Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota
###end article-title 148
###begin article-title 149
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
###end article-title 149
###begin article-title 150
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice
###end article-title 150
###begin article-title 151
Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages
###end article-title 151
###begin article-title 152
The immunology of mucosal models of inflammation
###end article-title 152
###begin article-title 153
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Interleukin-10-deficient mice develop chronic enterocolitis
###end article-title 153
###begin article-title 154
Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
###end article-title 154
###begin article-title 155
The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor
###end article-title 155
###begin article-title 156
###xml 94 98 <span type="species:ncbi:10090">mice</span>
A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice
###end article-title 156
###begin article-title 157
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Heritable susceptibility for colitis in mice induced by IL-10 deficiency
###end article-title 157
###begin article-title 158
Interleukin-10 and the interleukin-10 receptor
###end article-title 158
###begin article-title 159
IL-10 inhibits cytokine production by activated macrophages
###end article-title 159
###begin article-title 160
Regulatory activity of autocrine IL-10 on dendritic cell functions
###end article-title 160
###begin article-title 161
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF
###end article-title 161
###begin article-title 162
Transforming growth factor-beta regulation of immune responses
###end article-title 162
###begin article-title 163
###xml 25 31 <span type="species:ncbi:10090">murine</span>
Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity
###end article-title 163
###begin article-title 164
###xml 81 87 <span type="species:ncbi:10090">murine</span>
Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors
###end article-title 164
###begin article-title 165
###xml 2 8 <span type="species:ncbi:10090">murine</span>
###xml 18 39 <span type="species:ncbi:100816">Madurella mycetomatis</span>
A murine model of Madurella mycetomatis eumycetoma
###end article-title 165
###begin article-title 166
###xml 99 103 <span type="species:ncbi:10090">mice</span>
The use of metronidazole, tinidazole and dimetridazole in eliminating trichomonads from laboratory mice
###end article-title 166
###begin article-title 167
###xml 84 88 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice
###end article-title 167
###begin article-title 168
Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury
###end article-title 168
###begin article-title 169
Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5
###end article-title 169
###begin article-title 170
A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease
###end article-title 170
###begin article-title 171
Role of cytokines in the pathogenesis of inflammatory bowel disease
###end article-title 171
###begin article-title 172
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells
###end article-title 172
###begin article-title 173
###xml 178 182 <span type="species:ncbi:10090">mice</span>
The straw that stirs the drink: insight into the pathogenesis of inflammatory bowel disease revealed through the study of microflora-induced inflammation in genetically modified mice
###end article-title 173
###begin article-title 174
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 25 31 <span type="species:ncbi:9606">infant</span>
Development of the human infant intestinal microbiota
###end article-title 174
###begin article-title 175
Use of antibiotics in the treatment of inflammatory bowel disease
###end article-title 175
###begin article-title 176
T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells
###end article-title 176
###begin article-title 177
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10
###end article-title 177
###begin article-title 178
CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10
###end article-title 178
###begin article-title 179
Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis
###end article-title 179
###begin article-title 180
The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis
###end article-title 180
###begin article-title 181
Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms
###end article-title 181
###begin article-title 182
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor
###end article-title 182
###begin article-title 183
T cells in inflammatory bowel disease: protective and pathogenic roles
###end article-title 183
###begin article-title 184
A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
###end article-title 184
###begin article-title 185
Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells
###end article-title 185
###begin article-title 186
IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function
###end article-title 186
###begin article-title 187
In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines
###end article-title 187
###begin article-title 188
Interleukin 10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion
###end article-title 188
###begin article-title 189
Interleukin-10 and related cytokines and receptors
###end article-title 189
###begin article-title 190
IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration
###end article-title 190
###begin article-title 191
Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells
###end article-title 191
###begin article-title 192
Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts
###end article-title 192
###begin article-title 193
Inflammatory bowel disease: clinical aspects and established and evolving therapies
###end article-title 193
###begin article-title 194
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells
###end article-title 194
###begin article-title 195
###xml 138 142 <span type="species:ncbi:10090">mice</span>
Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice
###end article-title 195
###begin article-title 196
###xml 0 22 <span type="species:ncbi:32025">Helicobacter hepaticus</span>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism
###end article-title 196
###begin article-title 197
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses
###end article-title 197
###begin article-title 198
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
###end article-title 198
###begin article-title 199
Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology
###end article-title 199
###begin article-title 200
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12
###end article-title 200
###begin article-title 201
Anti-interleukin-12 antibody for active Crohn's disease
###end article-title 201
###begin article-title 202
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Antibodies to interleukin 12 abrogate established experimental colitis in mice
###end article-title 202
###begin article-title 203
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene
###end article-title 203
###begin article-title 204
IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6
###end article-title 204
###begin article-title 205
###xml 26 48 <span type="species:ncbi:32025">Helicobacter hepaticus</span>
IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis
###end article-title 205
###begin article-title 206
Interleukin-23 drives innate and T cell-mediated intestinal inflammation
###end article-title 206
###begin article-title 207
###xml 136 140 <span type="species:ncbi:10090">mice</span>
Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice
###end article-title 207
###begin article-title 208
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis
###end article-title 208
###begin article-title 209
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Keratin-8-deficient mice develop chronic spontaneous Th2 colitis amenable to antibiotic treatment
###end article-title 209
###begin article-title 210
###xml 162 166 <span type="species:ncbi:10090">mice</span>
Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice
###end article-title 210
###begin article-title 211
Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when
###end article-title 211
###begin article-title 212
Antimicrobials in the management of inflammatory bowel disease
###end article-title 212
###begin article-title 213
###xml 22 30 <span type="species:ncbi:9606">patients</span>
Optimizing therapy in patients with pancolitis
###end article-title 213
###begin article-title 214
Ulcerative colitis
###end article-title 214
###begin p 215
paragraph sign These authors are joint senior authors on this work.
###end p 215
###begin p 216
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
Author contributions. SSK, SMB, TSS, and PMA designed the study, analyzed the data, and wrote the paper. SSK, SMB, and LAN did the experiments. MJG performed the statistical analysis. RAF provided the dnTGFbetaRII mice and the expertise in their use.
###end p 216
###begin p 217
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding:</bold>
Funding: This work was supported by grants from the National Institutes of Health (NIH) and by a Cancer Research Institute predoctoral fellowship (SSK). The funders had no role in the study design, data collection, decision to publish or preparation of the manuscript.
###end p 217
###begin p 218
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests:</bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 218

